Indegene Limited (NSE:INDGN)
581.60
-14.10 (-2.37%)
Jun 6, 2025, 3:30 PM IST
Indegene Revenue
In the fiscal year ending March 31, 2025, Indegene had annual revenue of 28.39B INR with 9.64% growth. Indegene had revenue of 7.56B in the quarter ending March 31, 2025, with 12.28% growth.
Revenue
28.39B
Revenue Growth
+9.64%
P/S Ratio
4.92
Revenue / Employee
6.83M
Employees
4,367
Market Cap
139.59B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 271.45B |
Apollo Hospitals Enterprise | 217.94B |
Mankind Pharma | 122.07B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Alkem Laboratories | 129.65B |